Given the essential role of CD4+ T cells in the pathogenesis of RA, both directly and by recruiting and activating other participating cell types (such as B cells, DCs and macrophages), the therapeutic targeting of CD4+ lymphocytes has been extensively pursued [38]. Here, CD4 is linked to rheumatoid arthritis.